Maria Jaswal Selected Research

Pharmaceutical Preparations

1/2021	Safety and feasibility of 1 month of daily rifapentine plus isoniazid to prevent tuberculosis in children and adolescents: a prospective cohort study.
1/2019	Pharmacokinetics of Levofloxacin in Children Treated for Exposure to Drug-Resistant Tuberculosis.
1/2015	Determinants of Default from Tuberculosis Treatment among Patients with Drug-Susceptible Tuberculosis in Karachi, Pakistan: A Mixed Methods Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Jaswal Research Topics

Disease

5	Tuberculosis (Tuberculoses) 01/2021 - 01/2015
3	Infections 01/2021 - 01/2020
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2021 - 01/2015
2	rifapentine (Priftin)FDA Link 01/2021 - 01/2021
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2021 - 01/2021
1	FluoroquinolonesIBA 01/2020
1	Levofloxacin (Levaquin)FDA Link 01/2019

Therapy/Procedure

3	Therapeutics 01/2020 - 01/2015